Premium
Intravenous ( IV ) bortezomib infusion after non‐response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?
Author(s) -
Gozzetti Alessandro,
Candi Veronica,
Zuanelli Brambilla Corrado,
Papini Giulia,
Bocchia Monica
Publication year - 2017
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14032
Subject(s) - bortezomib , multiple myeloma , medicine , proteasome inhibitor , toxicity , pharmacodynamics , pharmacology , pharmacokinetics , gastroenterology , urology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom